Back to Search Start Over

Emergent BioSolutions Receives FDA Approval for Large-Scale Manufacturing of BioThrax in Building 55

Source :
Plus Company Updates. September 21, 2016
Publication Year :
2016

Abstract

Gaithersburg, Maryland: Emergent BioSolutions has issued the following news release: Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.465300920